CASC
Cascadian Therapeutics Inc
Clinical-stage biopharmaceutical company developing oncology therapeutics, formerly Oncothyreon Inc
CUSIP: 14740B606HealthcareUS1 holder
Total Value
$32.27M
Total Shares
8.72M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$32.27M8.72M sharesUnchanged